Your browser doesn't support javascript.
loading
Cross-sectional evaluation of health resource use in patients with functional neurological disorders referred to a tertiary neuroscience centre.
O'Mahony, Brian William; Nelson-Sice, Robert; Nielsen, Glenn; Hunter, Rachael; Cope, Sarah; Agarwal, Niruj; Edwards, Mark J; Yogarajah, Mahinda.
Affiliation
  • O'Mahony BW; Institute of Psychiatry at the Maudsley, London, UK.
  • Nelson-Sice R; University Hospital Galway, Galway, Ireland.
  • Nielsen G; St George's Healthcare NHS Trust, London, UK.
  • Hunter R; Institute of Molecular and Clinical Sciences, St George's University, London, UK.
  • Cope S; Primary Care and Population Health, University College London, London, UK.
  • Agarwal N; South West London and Saint George's Mental Health NHS Trust, London, UK.
  • Edwards MJ; Department of Neuropsychiatry, South West London and St George's Mental Health NHS Trust, London, UK.
  • Yogarajah M; St George's University of London, London, UK.
BMJ Neurol Open ; 6(1): e000606, 2024.
Article in En | MEDLINE | ID: mdl-38800070
ABSTRACT

Introduction:

Functional neurological disorder (FND) is a common cause of referral to neurology services. FND has been shown to lead to significant healthcare resource use and is associated with significant disability, comorbidity and distress. This leads to substantial direct, indirect and intangible costs to the patient and society.

Methods:

We recruited consecutive patients with FND referred to a tertiary FND specialist clinic. We assessed health and social care resource use in the 6 months preceding their consultation through a modified version of the Client Service Receipt Inventory in the form of a postal questionnaire. The total cost was estimated by combining the number and frequency of health resource use with standard national unit costs. We also assessed indirect costs such as informal care and loss of income.

Results:

We collected data on 118 subjects. Patients with comorbid anxiety or depression had higher costs in the preceding 6 months, as did patients who had a longer duration of FND symptoms. Indirect costs were higher than the already substantial direct costs and a large proportion of patients with FND were receiving government support.

Conclusion:

This study highlights the high cost of FND to both patients and health systems. Adequate reform of the patient pathway and reorganisation of services to make diagnoses and initiate treatment more quickly would likely reduce these costs.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BMJ Neurol Open Year: 2024 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BMJ Neurol Open Year: 2024 Type: Article Affiliation country: United kingdom